Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

Joo Hyun O; Brandon S. Luber; Jeffrey P. Leal; Hao Wang; Vanessa Bolejack; Scott M. Schuetze; Lawrence H. Schwartz; Lee J. Helman; Denise Reinke; Laurence H. Baker; Richard L. Wahl

doi:10.2967/jnumed.115.162412

Research ArticleClinical Investigations

Response to Early Treatment Evaluated with ¹⁸F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

Joo Hyun O, Brandon S. Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise Reinke, Laurence H. Baker and Richard L. Wahl

Journal of Nuclear Medicine May 2016, 57 (5) 735-740; DOI: https://doi.org/10.2967/jnumed.115.162412

Joo Hyun O

1Division of Nuclear Medicine, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brandon S. Luber

2Division of Biostatistics and Bioinformatics, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeffrey P. Leal

1Division of Nuclear Medicine, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hao Wang

2Division of Biostatistics and Bioinformatics, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vanessa Bolejack

3Cancer Research and Biostatistics, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Scott M. Schuetze

4Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lawrence H. Schwartz

5Department of Radiology, Columbia University, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lee J. Helman

6Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Denise Reinke

7SARC, Ann Arbor, Michigan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Laurence H. Baker

4Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard L. Wahl

1Division of Nuclear Medicine, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 57, Issue 5

May 1, 2016

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Response to Early Treatment Evaluated with ¹⁸F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

Joo Hyun O, Brandon S. Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise Reinke, Laurence H. Baker, Richard L. Wahl

Journal of Nuclear Medicine May 2016, 57 (5) 735-740; DOI: 10.2967/jnumed.115.162412

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Joo Hyun O, Brandon S. Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise Reinke, Laurence H. Baker, Richard L. Wahl

Journal of Nuclear Medicine May 2016, 57 (5) 735-740; DOI: 10.2967/jnumed.115.162412

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing
Preclinical PERCIST and 25% of SUVmax Threshold: Precision Imaging of Response to Therapy in Co-clinical 18F-FDG PET Imaging of Triple-Negative Breast Cancer Patient-Derived Tumor Xenografts

Google Scholar

Keywords

sarcoma
insulin-like growth factor
18F-FDG PET

Main menu

User menu

Search

Response to Early Treatment Evaluated with ¹⁸F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords